关注
Rahul Banerjee
Rahul Banerjee
Assistant Professor, Division of Medical Oncology
在 uw.edu 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Brexucabtagene autoleucel for relapsed or refractory mantle cell lymphoma in standard-of-care practice: results from the US lymphoma CAR T consortium
Y Wang, P Jain, FL Locke, MJ Maurer, MJ Frank, JL Munoz, S Dahiya, ...
Journal of clinical oncology 41 (14), 2594-2606, 2023
712023
Comparable outcomes in chronic lymphocytic leukaemia (CLL) patients treated with reduced‐dose ibrutinib: results from a multi‐centre study.
AR Mato, C Timlin, C Ujjani, A Skarbnik, C Howlett, R Banerjee, ...
British journal of haematology 181 (2), 2018
672018
Occurrence and recall rates of fertility discussions with young breast cancer patients
R Banerjee, E Tsiapali
Supportive Care in Cancer 24, 163-171, 2016
422016
The human alpha defensin HD5 neutralizes JC polyomavirus infection by reducing endoplasmic reticulum traffic and stabilizing the viral capsid
SR Zins, CDS Nelson, MS Maginnis, R Banerjee, BA O'Hara, WJ Atwood
Journal of virology 88 (2), 948-960, 2014
352014
Next-generation implementation of chimeric antigen receptor T-cell therapy using digital health
R Banerjee, N Shah, AP Dicker
JCO clinical cancer informatics 5, 668-678, 2021
272021
Financial toxicity in hematological malignancies: a systematic review
E Ouchveridze, R Banerjee, A Desai, M Aziz, W Lee-Smith, H Mian, ...
Blood cancer journal 12 (4), 74, 2022
262022
Medical student awareness of and interest in clinical informatics
R Banerjee, P George, C Priebe, E Alper
Journal of the American Medical Informatics Association 22 (e1), e42-e47, 2015
262015
Early time-to-tocilizumab after B cell maturation antigen-directed chimeric antigen receptor T cell therapy in myeloma
R Banerjee, J Marsal, CY Huang, M Lo, S Kambhampati, VE Kennedy, ...
Transplantation and Cellular Therapy 27 (6), 477. e1-477. e7, 2021
242021
Maximizing home time for persons with cancer
R Banerjee, M George, A Gupta
JCO Oncology Practice 17 (9), 513-516, 2021
212021
Are observational, real-world studies suitable to make cancer treatment recommendations?
R Banerjee, V Prasad
JAMA Network Open 3 (7), e2012119-e2012119, 2020
212020
Impact of second primary malignancy post–autologous transplantation on outcomes of multiple myeloma: a CIBMTR analysis
BK Ragon, MV Shah, A D’Souza, N Estrada-Merly, L Gowda, G George, ...
Blood advances 7 (12), 2746-2757, 2023
202023
Impact of induction therapy with VRD versus VCD on outcomes in patients with multiple myeloma in partial response or better undergoing upfront autologous stem cell transplantation
S Sidana, S Kumar, R Fraser, N Estrada-Merly, S Giralt, V Agrawal, ...
Transplantation and cellular therapy 28 (2), 83. e1-83. e9, 2022
202022
Lyme neuroborreliosis presenting with alexithymia and suicide attempts
R Banerjee, JJ Liu, HM Minhas
The Journal of clinical psychiatry 74 (10), 2374, 2013
152013
Safety and efficacy of BCMA CAR-T cell therapy in older patients with multiple myeloma
KR Reyes, CY Huang, M Lo, S Arora, A Chung, SW Wong, J Wolf, RL Olin, ...
Transplantation and Cellular Therapy 29 (6), 350-355, 2023
142023
The Democratization of Scientific Conferences: Twitter in the Era of COVID-19 and Beyond
R Banerjee, AH Kelkar, AC Logan, NS Majhail, N Pemmaraju
Current Hematologic Malignancy Reports, doi: 10.1007/s11899-021-00620-w, 2021
132021
Synthetic control arms in studies of multiple myeloma and diffuse large B‐cell lymphoma
R Banerjee, S Midha, AH Kelkar, A Goodman, V Prasad, GR Mohyuddin
British Journal of Haematology 196 (5), 1274-1277, 2022
122022
Toci or not toci: innovations in the diagnosis, prevention, and early management of cytokine release syndrome
R Banerjee, B Fakhri, N Shah
Leukemia & Lymphoma 62 (11), 2600-2611, 2021
122021
Driving distance and patient-reported outcomes in hematopoietic cell transplantation survivors
R Banerjee, CY Jean, NS Majhail, HSL Jim, J Uberti, V Whalen, AW Loren, ...
Biology of Blood and Marrow Transplantation 26 (11), 2132-2138, 2020
122020
Clinical outcomes and salvage therapies in patients with relapsed/refractory multiple myeloma following progression on BCMA-targeted CAR-T therapy
KR Reyes, YC Liu, CY Huang, R Banerjee, T Martin, N Shah, SW Wong, ...
Blood 140 (Supplement 1), 617-619, 2022
102022
Maintenance therapy after second autologous hematopoietic cell transplantation for multiple myeloma. A CIBMTR analysis
O Pasvolsky, M Yeshurun, R Fraser, N Estrada-Merly, U Rozovski, ...
Bone marrow transplantation 57 (1), 31-37, 2022
102022
系统目前无法执行此操作,请稍后再试。
文章 1–20